Privileged Quinolylnitrones for the Combined Therapy of Ischemic Stroke and Alzheimer's Disease
Cerebrovascular diseases such as ischemic stroke are known to exacerbate dementia caused by neurodegenerative pathologies such as Alzheimer's disease (AD). Besides, the increasing number of patients surviving stroke makes it necessary to treat the co-occurrence of these two diseases with a sing...
Saved in:
Main Authors: | José M. Alonso (Author), Alejandro Escobar-Peso (Author), Alejandra Palomino-Antolín (Author), Daniel Diez-Iriepa (Author), Mourad Chioua (Author), Emma Martínez-Alonso (Author), Isabel Iriepa (Author), Javier Egea (Author), Alberto Alcázar (Author), José Marco-Contelles (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Improving the Efficacy of Quinolylnitrones for Ischemic Stroke Therapy, QN4 and QN15 as New Neuroprotective Agents after Oxygen-Glucose Deprivation/Reoxygenation-Induced Neuronal Injury
by: José M. Alonso, et al.
Published: (2022) -
Characterization of a CholesteroNitrone (ISQ-201), a Novel Drug Candidate for the Treatment of Ischemic Stroke
by: Emma Martínez-Alonso, et al.
Published: (2020) -
Development of Pharmacological Strategies with Therapeutic Potential in Ischemic Stroke
by: Alejandro Escobar-Peso, et al.
Published: (2023) -
Preclinical Characterization of Antioxidant Quinolyl Nitrone QN23 as a New Candidate for the Treatment of Ischemic Stroke
by: Emma Martínez-Alonso, et al.
Published: (2022) -
Neuroprotective and Antioxidant Properties of CholesteroNitrone ChN2 and QuinolylNitrone QN23 in an Experimental Model of Cerebral Ischemia: Involvement of Necrotic and Apoptotic Cell Death
by: Beatriz Chamorro, et al.
Published: (2023)